ReviewJournal of personalized medicine2026

Cardiovascular and Thromboembolic Risk of Janus Kinase Inhibitors Compared to Other Disease-Modifying Drugs in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.

Diomidis C Ioannidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.